Syzygy Biotech Nabs $100K Investment for PCR Reagent Development | GenomeWeb

This article has been corrected from a previous version to correct misinformation regarding the current name of Syzygy Biotech.

Syzygy Biotech, a Grand Rapids, Mich.-based PCR reagents shop, has received a $100,000 investment from the Michigan Pre-Seed Capital Fund, fund administrator Ann Arbor Spark said today.

Syzygy, which was formed under the name Seedus Biotech, manufactures low-cost reagents such as Taq polymerases and master mixes for use in DNA amplification.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.